Lord, Abbett & Co. LLC Biogen Inc. Transaction History

Lord, Abbett & Co. LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 07, 2024	SELL	$222.59 - $267.94 $437,611 - $526,770	-1,966 Reduced 1.22%	159,399 $41.2 Million
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $437,611 - $526,770	-1,966 Reduced 1.22%	159,399 $41.2 Million
Q3 2023 Oct 07, 2024	BUY	$253.3 - $285.89 $6.54 Million - $7.38 Million	25,818 Added 19.05%	161,365 $41.5 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $6.54 Million - $7.38 Million	25,818 Added 19.05%	161,365 $41.5 Million
Q2 2023 Oct 07, 2024	SELL	$275.25 - $318.06 $35.4 Million - $41 Million	-128,768 Reduced 48.72%	135,547 $38.6 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $37.3 Million - $43.1 Million	135,547 New	135,547 $38.6 Million
Q4 2022 Oct 07, 2024	BUY	$252.44 - $306.72 $66.7 Million - $81.1 Million	264,315 New	264,315 $73.2 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $63.1 Million - $76.6 Million	249,884 Added 1731.58%	264,315 $73.2 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $2.81 Million - $3.87 Million	14,431 New	14,431 $3.85 Million
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $53.1 Million - $69.3 Million	-187,722 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $48.6 Million - $77.9 Million	187,722 New	187,722 $65 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $18.2 Million - $23.1 Million	-65,425 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $19.2 Million - $25.1 Million	65,425 New	65,425 $23.1 Million

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.